Search Tag: Dianthus Therapeutics
2023 20 Jun
Experienced life sciences executive brings more than a decade of public company expertise in legal, corporate governance and compliance Dianthus Therapeutics, a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics announced the appointment of Adam Veness, Esq., as General Counsel. Joining...Read more
2023 17 Jan
Appointment adds over 25 years of expertise in early discovery research, clinical drug development and strategic partnerships, with deep focus in immunology therapeutic areas Kalled joins an executive team of industry leaders and scientists pioneering the next generation of antibody complement therapeutics for people living with severe autoimmune...Read more